New offering identifies COVID-19 and Influenza infections with a single sample ELMWOOD PARK, N.J., October 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the […]
Search Results for: log in
Press Release
OPKO Health’s BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
09
Oct
Oct
Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools ELMWOOD PARK, N.J., October 9, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school […]
06
Oct
Oct
Every October, we are surrounded by a sea of pink to inspire hope and raise awareness of breast cancer. The month is dedicated to educating the public about breast cancer early detection, causes, prevention, treatment, support services and more. According to the American Cancer Society, breast cancer is the second most common cancer in American […]
Wall Street Journal BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season Technicians processed incoming Covid-19 tests at BioReference Laboratories in Elmwood Park, N.J. ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved […]
Press Release
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
02
Sep
Sep
The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]
Press Release
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
01
Sep
Sep
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
ELMWOOD PARK, N.J., August 18, 2020 – BioReference Laboratories Inc., an OPKO Health Company, is pleased to announce it is now in-network with all Blue Cross and Blue Shield of Texas (BCBSTX) products, including its Health Maintenance Organization (HMO) and Medicaid lines of business. The contract includes BioReference’s subsidiary GeneDx, Inc., a full service genetics […]
Forbes The company testing NBA players in the Orlando bubble is tackling a unique logistical challenge in order to facilitate a “greater good,” according to the man in charge of testing NBA players to ensure they are not positive for COVID-19. Bio-Reference Laboratories has about 100 people working inside and outside of the NBA bubble […]
Press Release
Geoff Monk, President of OPKO Health’s BioReference Laboratories, Named to CEO Today’s Healthcare 2020 Awards List
21
Jul
Jul
ELMWOOD PARK, N.J., July 21, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company, today announced that Geoff Monk, President of BioReference Laboratories, was recognized by CEO Today Magazine as one of this year’s 20 Healthcare Award winners. Every year, CEO Today Magazine identifies and honors the most respected companies and their executives who lead the way on the global stage. CEO Today Magazine’s Healthcare Awards acknowledge […]
Press Release
OPKO Health’s BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)
20
Jul
Jul
CDC chooses BioReference as one of the antibody testing and service providers for national serological survey ELMWOOD PARK, N.J., July 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the […]
